InvestorsHub Logo
Followers 11
Posts 1565
Boards Moderated 0
Alias Born 09/19/2006

Re: SJSTOCKSHARK post# 169

Friday, 10/08/2010 3:12:31 PM

Friday, October 08, 2010 3:12:31 PM

Post# of 359
The stock price has held up well in light of the low volume and lack of news.

I am surprised at the lack of buzz about this stock after the Zacks report. Since Yak didn't post this article here, I will.

"CardioGenics Featured on Cover of Medical Device & Diagnostic Industry Magazine
Wed Oct 6, 9:00 AM


MISSISSAUGA, Ontario, Oct. 6 /PRNewswire/ -- Dr. Yahia Gawad, CEO of CardioGenics Inc. (OTC Bulletin Board: CGNH.OB), has authored a cover story for this month's Medical Device & Diagnostic Industry Magazine (MD+DI) which addresses improvements in diagnostic times using point-of-care technology. In the article, titled "Improving Diagnosis Times with New Point-of-Care Technology," Dr. Gawad reviews the in-vitro diagnostics market and the growth of point-of-care testing.


In addition to reviewing other point-of-care devices, Dr. Gawad describes the operation of the QL Care Analyzer(TM), CardioGenics' point-of-care immunoassay platform that will allow a heart attack diagnosis to be made in as little as 15 minutes vs. the national average of 2.8 hours required for test results from a central lab. CardioGenics expects to submit to the FDA a 510K application for the QL Care Analyzer(TM) (and its first cardiac test, Troponin-I) during Q1 2011 and to have both commercialized by Q2 2011.


The article can be accessed online at:

http://www.mddionline.com/article/improving-diagnosis-times-new-point-care-technology


About Medical Device & Diagnostics Industry


Medical Device & Diagnostic Industry is a leading monthly magazine written exclusively for original equipment manufacturers of medical devices and in vitro diagnostic products. The goal of MD&DI is to help industry professionals develop, design, and manufacture medical products that comply with complex and demanding regulations and market requirements. MD&DI is published 12 times each year, along with two additional issues of its Guide to Outsourcing supplement.




This company's PR firms are doing an excellent job, so where is the buzz?